Bridgepoint Development Capital is to acquire a majority shareholding in Vitamin Well, a high growth, market-leading business in the functional drinks sector with sales in 28 countries.

Established in Stockholm in 2006, the company develops, markets and sells products for health conscious and active consumers under the drinks brands Vitamin Well, Vitamin Well FREE, NOBE aloe vera, NOCCO and Vitamin Well+.

The transaction is conditional upon merger clearance and is expected to close before the end of the first quarter of 2017.

The main shareholders are advised by Mannheimer Swartling in the transaction.